Quantitative Androgen Deficiency in the Aging Male (qADAM)

Summary

The qADAM (quantitative Androgen Deficiency in the Aging Male) questionnaire is an enhanced screening tool for potential low testosterone (hypogonadism) that provides a measure of symptom severity. The qADAM is a quantitative modification of the original ADAM questionnaire. The original 10 questions are property of Saint Louis University and were developed by John E. Morley, M.B., B.Ch. The quantitative scoring system was validated and published by Mohamed et al. (2010).

• For the Questions (Original ADAM): Morley, J. E., Charlton, E., Patrick, P., Kaiser, F. E., Cadeau, P., McCready, D., & Perry, H. M., III. (2000). Validation of a screening questionnaire for androgen deficiency in aging males. Metabolism, 49(9), 1239–1242.

• For the Scoring System (qADAM): Mohamed, O., Freundlich, R. E., Dakik, H. K., Grober, E. D., Najari, B., Lipshultz, L. I., & Khera, M. (2010). The quantitative ADAM questionnaire: a new tool in quantifying the severity of hypogonadism. International Journal of Impotence Research, 22(1), 20–24.

The most critical difference is the scoring mechanism:

*Note: Q6 in the ADAM maps to Q6 in the qADAM

Questions

The qADAM uses the same 10 symptom questions as the original ADAM, but rephrases them slightly to facilitate a graded response. Each question is scored on a 5-point scale, and the score for each question is added together to get the total.

Scoring 

The scoring is consistently set up so that a higher score reflects fewer or less severe symptoms (a better outcome).

The standard 5-point Likert scale and corresponding score values are:

Interpretation:

Score of 10: Most symptomatic (maximal androgen deficiency suggested).

Score of 50: Least symptomatic (hormonal status likely optimal based on symptoms).

Clinical Utility: The score's value lies in its correlation with serum testosterone levels (demonstrated in studies) and its ability to measure a clinically meaningful improvement (often defined as an increase of ≥ 5 points) after initiating treatment. The qADAM is a powerful tool because it provides a quantitative metric that can be tracked over time, giving doctors a non-invasive way to monitor a patient's quality of life and response to hormonal therapy.

 Results include:

• Total Score ##

• You may be experiencing androgen deficiency (If score < 47 OR Q1 is NOT Excellent OR Q6 is NOT Extremely Strong)

• It is unlikely that you are experiencing androgen deficiency (If score > 47)

The qADAM is a quantitative modification of the original ADAM questionnaire. The original 10 questions are property of Saint Louis University and were developed by John E. Morley, M.B., B.Ch. The quantitative scoring system was validated and published by Mohamed et al. (2010).

• For the Questions (Original ADAM): Morley, J. E., Charlton, E., Patrick, P., Kaiser, F. E., Cadeau, P., McCready, D., & Perry, H. M., III. (2000). Validation of a screening questionnaire for androgen deficiency in aging males. Metabolism, 49(9), 1239–1242.
• For the Scoring System (qADAM): Mohamed, O., Freundlich, R. E., Dakik, H. K., Grober, E. D., Najari, B., Lipshultz, L. I., & Khera, M. (2010). The quantitative ADAM questionnaire: a new tool in quantifying the severity of hypogonadism. International Journal of Impotence Research, 22(1), 20–24.